Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. has received drug registration certificates for low-calcium peritoneal dialysis solutions, which will enhance the company's product line and market competitiveness [1] Group 1: Product Development - The company’s wholly-owned subsidiary, Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd., has obtained registration for low-calcium peritoneal dialysis solutions (bicarbonate-G1.5% and bicarbonate-G2.5%) [1] - The registration of these products will enrich the company's product offerings and contribute to its competitive edge in the market [1] - The experience gained from the development of these products will be valuable for future product research and development [1]
华润双鹤(600062.SH):子公司低钙腹膜透析液(碳酸氢盐)、腹膜透析液(碳酸氢盐)系列药品获得药品注册证书